Thomas McCauley, PhD, on Potential Advantages of Epigenetic Therapy Over Small Molecule, Gene Therapy
The chief scientific officer at Omega Therapeutics discussed the issues with other modes of therapies that OEC therapy may address.
Thomas McCauley, PhD, on the Potential of Epigenetics for Therapy Development
The chief scientific officer at Omega Therapeutics discussed the importance of understanding more about and researching epigenetics.
Thomas McCauley, PhD, on Treating Solid Tumors With Epigenomic Controllers
The chief scientific officer at Omega Therapeutics discussed positive preclinical data presented at ASCO 2023.
